Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Lutein + Zeaxanthin wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
16 of 17 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
3 of 3 studies with measurable effects showed benefit.
Top outcomes
10mg lutein + 2mg zeaxanthin
With a meal containing fat
Softgels with both lutein and zeaxanthin
100-200mg standardized extract daily
Once or twice daily, With or without food
Standardized extract (13-14% sterols)
3-6 months
4-8 weeks
3-6 months
6-8 weeks
6-8 weeks
8-12 weeks
The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis
The American journal of clinical nutrition (2016) · Meta analysis · n=387569
Meta-analysis showed a lower risk of coronary heart disease (pooled RR: 0.88; 95% CI: 0.80, 0.98) and stroke (pooled RR: 0.82; 95% CI: 0.72, 0.93) for the highest compared with the lowest tertile of lutein blood concentration or intake.
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
The Cochrane database of systematic reviews (2023) · Systematic review · n=2445
These studies enroled 11,952 people aged 65 to 75 years and included slightly more women (on average 56% women).
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28
JAMA ophthalmology (2022) · Rct · n=3882
This study included 3882 participants (mean [SD] baseline age, 72.0 [7.7] years; 2240 women [57.7%]) and 6351 eyes.
What do we know about phytotherapy of benign prostatic hyperplasia?
Life sciences (2015) · Systematic review
On the basis of preclinical studies several mechanisms of action have been postulated, including 5alpha-reductase inhibition, alpha-adrenergic antagonism, dihydrotestosterone and estrogen receptor inhibition.
Phytotherapy of benign prostatic hyperplasia. A minireview
Phytotherapy research : PTR (2014) · Systematic review
Histological BPH, which typically develops after the age of 40 years, ranges in prevalence from >50% at 60 years to as high as 90% by 85 years of age.
Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS)
BMJ clinical evidence (2011) · Systematic review
We found 63 systematic reviews, RCTs, or observational studies that met our inclusion criteria.
Based on multiple meta-analyses showing significant MPOD increases in both AMD patients and healthy subjects. Effect size modest but consistent across studies. Higher doses may increase carotenodermia risk.
Based on Cochrane review (n=1562) and network meta-analysis showing modest benefits. Evidence quality noted as low-to-moderate due to dated methodology in available RCTs. Most studies used standardized bark extract.
AI-estimated from published studies. Interpret as directional guidance.
Lutein + Zeaxanthin has a higher evidence score (7.5/10 vs 5.5/10) and wins in 2 of 3 categories.
For healthy aging, Lutein + Zeaxanthin has a higher relevance score (95 vs 85).
No known interactions between Lutein + Zeaxanthin and Pygeum have been documented in our database. However, always consult a healthcare provider before combining supplements.